An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc has announced a decrease in the number of CHESS Depositary Interests (CDIs) issued over quoted securities for February 2025, with a net reduction of 694,860 CDIs compared to the previous month. This change is attributed to net transfers of securities between CDIs and common stock as quoted on the NYSE. Additionally, there was a decrease in the total number of securities over which CDIs have not been issued, due to transfers, new share issues related to stock options and employee plans, and share repurchases on the NYSE. These adjustments reflect ResMed’s ongoing management of its securities and share structure, potentially impacting its market positioning and stakeholder interests.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep disorders and respiratory care. The company is known for its innovative solutions in sleep apnea therapy and has a significant presence in the global market.
YTD Price Performance: 1.17%
Average Trading Volume: 1,026,255
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.08B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.